Formation of adriamycin-DNA adductsin vitro
Open Access
- 1 January 1994
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 22 (12) , 2296-2303
- https://doi.org/10.1093/nar/22.12.2296
Abstract
Adriamycin is known to induce the formation of adducts with DNA when reacted under in vitro transcription conditions. The factors affecting the extent of adduct formation were examined in order to establish the critical components and optimal conditions required for the reaction, and to gain insight into the nature of the DNA-adduct complex. There was a strong dependence on reaction temperature (with a 40-fold increase of adducts at 40–50°C compared to 10°C), pH (maximum adducts at pH 7), but little dependence on the oxygen level. There was an absolute requirement for a reducing agent, with adducts detected with DTT, β-mercaptoethanol and glutathione, maximal adducts were formed at high levels of DTT (5–10 mM). Adducts were also formed with a xanthine oxidase/NADH reducing system, with increasing amounts of adducts detected with increasing NADH; no adducts were detected in the absence of either the enzyme or NADH. Of fourteen derivatives studied, only four yielded a similar extent of adduct formation as adriamycin; there was no absolute requirement for a carbonyl at C13 or hydroxyl at C14. Adducts were also observed with ssDNA but required a longer reaction time compared to dsDNA. The sequence specificity of adduct formation with ssDNA was examined using a primer-extension assay; almost all adducts were associated with a guanine residue. Overall, the results are consistent with a two-step reaction mechanism involving reductive activation of adriamycin, with the activated species then reacting with the guanine residues of either dsDNA or ssDNA.Keywords
This publication has 35 references indexed in Scilit:
- DNA topoisomerase-trapping antitumour drugsEuropean Journal Of Cancer, 1992
- Iron(III) binding in DNA solutions: Complex formation and catalytic activity in the oxidation of hydrazine derivativesChemico-Biological Interactions, 1991
- Induction of stable transcriptional blockage sites by Adriamycin: GpC specificity of apparent Adriamycin-DNA adducts and dependence on iron(III) ionsBiochemistry, 1990
- Comparison of dna cleavage induced by etoposide and doxorubicin in two human small‐cell lung cancer lines with different sensitivities to topoisomerase ii inhibitorsInternational Journal of Cancer, 1990
- Free radicals in anticancer drug pharmacologyChemico-Biological Interactions, 1989
- DNA sequence‐specific adducts of adriamycin and mitomycin CFEBS Letters, 1989
- Role of Daunosamine and Hydroxyacetyl Side Chain in Reaction With Iron and Lipid Peroxidation by AnthracyclinesJNCI Journal of the National Cancer Institute, 1988
- High-affinity iron binding by xanthine oxidaseJournal of Free Radicals in Biology & Medicine, 1986
- Binding of transferrin‐iron by adriamycin at acidic pHFEBS Letters, 1986
- Solution chemistry studies of adriamycin-iron complexes present in vivoPublished by Elsevier ,1980